Теракап131

Sodium Iodide (131I) is a radioactive iodine treatment used in thyroid therapy and diagnostic imaging. This EU-sourced oral solution supports thyroid function management with targeted radiation. Ideal for patients seeking thyroid-related care with a trusted radiopharmaceutical. Short version: Sodium Iodide (131I) oral solution for thyroid therapy and imaging, EU-sourced radiopharmaceutical for targeted care.

Sodium Iodide (131I) is primarily used in the treatment of thyroid conditions, including hyperthyroidism and thyroid cancer. It is also utilized in diagnostic imaging to assess thyroid function and structure. This radiopharmaceutical helps manage thyroid-related disorders by targeting thyroid cells with radiation. Patients often ask, what is Sodium Iodide (131I) used for, particularly in thyroid health management.

Sodium Iodide (131I) works by emitting radiation that targets thyroid cells, reducing overactive thyroid function or destroying cancerous cells. Patients may notice improved thyroid hormone regulation over time. The effects are gradual and depend on individual thyroid health and treatment goals. It is not an immediate solution but supports long-term thyroid management.

Sodium Iodide (131I) is a radioactive substance and should be handled with care. Pregnant or breastfeeding individuals should avoid this treatment due to potential risks. Patients must follow healthcare provider instructions for preparation and post-treatment care to minimize exposure to others. Proper disposal and hygiene practices are essential.

Sodium Iodide (131I) may interact with medications that affect thyroid function, such as thyroid hormones or antithyroid drugs. Patients should inform their healthcare provider about all medications, supplements, or recent medical procedures. Alcohol and certain foods may also influence thyroid activity, so dietary adjustments may be recommended during treatment.